• OPEN AN ACCOUNT
Indian Indices
Sensex
73,580.54 -1,247.71
( -1.67%)
Global Indices
Nasdaq
51,370.81 -161.78
(-0.31%)
Dow Jones
7,725.73 -1.30
(-0.02%)
Hang Seng
65,657.92 638.97
(0.98%)
Nikkei 225
10,680.49 -24.77
(-0.23%)
Forex
USD-INR
95.65 -0.17
(-0.17%)
EUR-INR
109.56 -0.37
(-0.34%)
GBP-INR
127.74 -0.44
(-0.34%)
JPY-INR
0.61 0.00
(-0.29%)

EQUITY - MARKET SCREENER

Nectar Lifescience Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
532649
INE023H01027
29.975558
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
NECLIFE
0
211.55
EPS(TTM)
Face Value()
Div & Yield %
0
1
0
 
( Cr)
ParticularsJun 2026 ( Cr)Mar 2026 ( Cr)Dec 2025 ( Cr)
Gross Sales0.010.000.00
Other Operating Income0.431.290.00
Other Income 6.176.2935.46
Total Income6.627.5835.46
Total Expenditure 27.6889.231.92
PBIDT-21.07-81.6533.53
Interest 0.165.9030.22
PBDT-21.22-87.553.31
Depreciation0.110.080.06
Tax0.000.000.00
Fringe Benefit Tax0.000.000.00
Deferred Tax-8.20-19.71-11.02
Reported Profit After Tax-13.14-67.9214.27
Extra-ordinary Items 0.32-30.7134.80
Adjusted Profit After Extra-ordinary item-13.46-37.21-20.53
EPS (Unit Curr.)-2.21-3.380.64
EPS (Adj) (Unit Curr.)-2.21-3.380.64
Calculated EPS (Unit Curr.)-0.68-3.500.64
Calculated EPS (Adj) (Unit Curr.)-0.68-3.500.64
Calculated EPS (Ann.) (Unit Curr.)-2.70-13.982.55
Calculated EPS (Adj) (Ann.) (Unit Curr.)-2.70-13.982.55
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity19.4319.4322.43
Reserve & Surplus0.000.000.00
Face Value1.001.001.00
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
PBIDTM(%)-210700.000.000.00
PBDTM(%)-212200.000.000.00
PATM(%)-131400.000.000.00